Find a Tender
complete
Official procurement procedure
Saphyr BioNano System - Bionano Genomics
Laboratory
optical and precision equipments (excl. glasses)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: BELFAST HEALTH AND SOCIAL CARE TRUST: "Saphyr BioNano System - Bionano Genomics". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | BELFAST HEALTH AND SOCIAL CARE TRUST | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: BELFAST HEALTH AND SOCIAL CARE TRUST
Market Analytics
Derived from OCDS awards & bid statistics
Published history for BELFAST HEALTH AND SOCIAL CARE TRUST. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 240 active published awards; 229 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityBELFAST HEALTH AND SOCIAL CARE TRUST | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published11 Feb 2022, 10:05 GMT | Last source update11 Feb 2022, 10:05 GMT | Recurring procurementNot published |
ClassificationLaboratory, optical and precision equipments (excl. glasses) | ||
Delivery area | ||
OCIDocds-h6vhtk-030c87 | ||
What is being bought
Saphyr BioNano System - Bionano Genomics
What changed
From the official release history
- Official notice release published
11 Feb 2022, 10:05 GMT - Status changed to complete
18 Jan 2022, 17:19 GMT - Official notice release published
18 Jan 2022, 17:19 GMT - Buyer information updated
18 Jan 2022, 17:19 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedSaphyr BioNano System - Bionano GenomicsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
11 Feb 2022, 10:05 GMT - Award active
Not published · Not published - Contract active
Signed 7 Feb 2022, 00:00 GMT · £300,000
Commercial outcome and competition
Awards Bionano Genomics UK Ltd Not published · Not published · active |
Contracts Saphyr BioNano System - Bionano Genomics £300,000 · signed 7 Feb 2022, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
BELFAST HEALTH AND SOCIAL CARE TRUST
Contracting authority GB-FTS-4486Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleNo other reasonable alternative exists for this procurement as this service is essential to patient care and service delivery. This is a highly specialised element of the service, this system is capable of analysing genomes of the complexity and size of the human genome providing the required diagnostic utility. A tender process has been delayed due to Covid19 and available resources, this procurement is required to cover the interim period until that process can be completed. A replacement in the short-term is not a reasonable alternative as it would require extensive and robust validation and verification work that would result in significant disruption and disproportionate technical difficulties that would significantly impact on patient care and the Trusts ability to deliver services. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement. |